Company Analysis

Evotec SE (EVO)

Nasdaq: EVO · Pharmaceutical Preparations · Hamburg, DE · filing with the SEC since 2007
Grade5.1
◀ Past 6.5● Present 5.6▶ Future 3.0
1 est.

Income statement, as filed

In thousands of euros (EUR), as filed; per-share figures in euros; share counts. The fiscal year ends in December.

The Form 20-F filed Apr 8, 2026 for the period ended Dec 31, 2025 is not in EDGAR's company facts yet; its figures here are that filing's own, read from the SEC's financial statement data sets.

Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedApr 8, 2026Apr 17, 2025Aug 14, 2024May 12, 2023Apr 26, 2022··
Revenue788,373796,967781,426751,448618,034500,924446,437
Cost of revenue674,152682,086606,375577,383466,491375,181313,546
Gross profit114,221114,881175,051174,065151,543125,743132,891
Research and development37,50950,85768,52976,64272,20063,94558,432
Selling, general and administrative175,970188,201169,610156,190105,44577,20566,433
Sales and marketing·17,47816,86913,4919,4229,5039,094
Operating income-56,217-142,522-47,50720,85040,99648,55662,707
Finance costs···13,1509,2548,4657,456
Interest income···8,3362,2721,3392,232
Share of profit of equity-method investments···-15,964-16,570-10,434-2,210
Income before income taxes-86,766-193,977-80,593-153,957236,98025,84056,675
Income tax expense16,7512,1023,32021,69821,47019,56219,363
Net income-103,517-196,078-83,913-175,655215,5106,27837,312
Net income to non-controlling interests······-844
Net income to shareholders···-175,655215,5106,27838,156
Earnings per share, basic-0.58-1.11-0.47-0.991.300.040.25
Earnings per share, diluted-0.58-1.11-0.47-0.991.300.040.25
Weighted average shares, basic177,578,262177,295,234176,916,663176,674,341166,405,926153,752,241149,725,607
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldifrs-full:Revenue
Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales
Gross profit revenue less the cost of what it soldifrs-full:GrossProfit
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense
Sales and marketing the cost of finding and serving customersifrs-full:SalesAndMarketingExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:InterestExpense
Interest income what its cash and investments earnedifrs-full:RevenueFromInterest
Share of profit of equity-method investments its share of companies it partly ownsifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests
Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
SI Assistanton EVO · research, not advice